Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
In ₹ Crore except Per Share Latest Annual | LOTUSEYE FY26 | GPTHEALTH FY26 | GKSL FY26 | SHALBY FY26 | Peer Average | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 2750.00× | ◆ 26.58× | 69.02× | 37.76× | 44.45× +6086% | |
| P/B | 3.80× | 4.17× | 5.37× | ◆ 1.30× | 3.61× +5% | |
| EV/EBITDA | 69.87× | 12.97× | 48.88× | ◆ 12.38× | 24.74× +182% | |
| Market Cap | ₹229 Cr | ₹1,123 Cr | ₹1,355 Cr | ₹1,311 Cr | ₹1,263 Cr -82% | |
| Growth | ||||||
| Revenue CAGR 3Y | 4.52% | — | — | ◆ 12.35% | 12.35% -63% | |
| Revenue CAGR 5Y | 10.66% | — | — | — | — | |
| Net Income CAGR 3Y | -72.98% | — | — | ◆ -19.97% | -19.97% -265% | |
| Revenue YoY (latest Q) | ◆ 26.19% | 17.83% | — | 11.74% | 14.79% +77% | |
| Net Income YoY (latest Q) | 12.65% | ◆ 65.73% | — | 36.70% | 51.22% -75% | |
| Profitability | ||||||
| EBITDA Margin | 6.30% | 17.81% | ◆ 32.85% | 12.51% | 21.06% -70% | |
| Net Income Margin | 0.15% | 8.93% | ◆ 20.50% | 3.04% | 10.82% -99% | |
| Return on Common Equity | 0.13% | ◆ 16.32% | 6.14% | 3.74% | 8.73% -99% | |
| Return on Capital Employed | -0.54% | ◆ 16.42% | 8.24% | 5.79% | 10.15% -105% | |
| Return on Assets | 0.11% | ◆ 9.95% | 5.65% | 1.96% | 5.85% -98% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.19× | ◆ 0.06× | 0.06× | 0.54× | 0.22× -14% | |
| Interest Coverage | -0.43× | 6.93× | ◆ 11.84× | 1.87× | 6.88× -106% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹53.7 Cr | ₹473 Cr | ₹82 Cr | ₹1,141 Cr | ₹565 Cr -90% | |
| Net Income | ₹0.1 Cr | ₹42.2 Cr | ₹16.8 Cr | ₹34.7 Cr | ₹31.2 Cr -100% | |
| Total Assets | ₹82.6 Cr | ₹465 Cr | ₹298 Cr | ₹1,839 Cr | ₹867 Cr -90% | |
| EPS | ₹0.04 | ₹5.15 | ₹2.49 | ₹3.23 | ₹3.62 -99% | |
| Book Value per Share | ₹28.92 | ₹32.84 | ₹32.03 | ₹93.49 | ₹52.79 -45% | |